From circulating biomarkers to genomics and imaging in the prediction of cardiovascular events in the general population.

Research output: Contribution to journalArticle

Standard

From circulating biomarkers to genomics and imaging in the prediction of cardiovascular events in the general population. / Fava, Cristiano; Montagnana, Martina; Guidi, Gian Cesare; Melander, Olle.

In: Annals of Medicine, Vol. 44, No. 5, 2012, p. 433-447.

Research output: Contribution to journalArticle

Harvard

APA

CBE

MLA

Vancouver

Author

RIS

TY - JOUR

T1 - From circulating biomarkers to genomics and imaging in the prediction of cardiovascular events in the general population.

AU - Fava, Cristiano

AU - Montagnana, Martina

AU - Guidi, Gian Cesare

AU - Melander, Olle

PY - 2012

Y1 - 2012

N2 - Abstract Cardiovascular disease (CVD) is the leading cause of death and disability worldwide. In the last decades numerous markers have been considered and investigated for the prediction of CV events, but only a few of them resulted in improved global risk assessment beyond traditional risk factors when incorporated into coronary evaluation scores. Recent genetic studies have pointed out a few but consistent loci or genes which are independently associated with CV risk. The idea is fascinating that these genetic markers could lead to improved individual CV risk assessment and tailored pharmacological interventions. In this brief review we will not make a systematic review of all non-genetic and genetic markers of CV risk but we will try to make a brief overview of the most interesting ones with the aim to underline potential 'pros' and 'cons' of their implementation in clinical practice.

AB - Abstract Cardiovascular disease (CVD) is the leading cause of death and disability worldwide. In the last decades numerous markers have been considered and investigated for the prediction of CV events, but only a few of them resulted in improved global risk assessment beyond traditional risk factors when incorporated into coronary evaluation scores. Recent genetic studies have pointed out a few but consistent loci or genes which are independently associated with CV risk. The idea is fascinating that these genetic markers could lead to improved individual CV risk assessment and tailored pharmacological interventions. In this brief review we will not make a systematic review of all non-genetic and genetic markers of CV risk but we will try to make a brief overview of the most interesting ones with the aim to underline potential 'pros' and 'cons' of their implementation in clinical practice.

U2 - 10.3109/07853890.2011.582511

DO - 10.3109/07853890.2011.582511

M3 - Article

C2 - 21623699

VL - 44

SP - 433

EP - 447

JO - Annals of Medicine

JF - Annals of Medicine

SN - 1365-2060

IS - 5

ER -